IRulya Therapeutics Inc. (IRLA) — Institutional Holders, Q2 2026

27 institutional investment managers reported a IRLA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $17.3M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

IRLA 13F holders ranked 1–27 of 27

Institutional investors reporting a position in IRulya Therapeutics Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
BALYASNY ASSET MANAGEMENT L.P.#1 · 69,967 sh$12.6MNew
Ikarian Capital#2 · 72,251 sh$1.3MNew
MILLENNIUM MANAGEMENT#3 · 70,779 sh$1.3M-97.2%
Squadron Capital Management#4 · 40,375 sh$734.4KNew
Shay Capital#5 · 17,468 sh$329.3K-99.0%
BOOTHBAY FUND MANAGEMENT#6 · 13,911 sh$253.0KNew
JANE STREET GROUP#7 · 12,642 sh$230.0KNew
VANGUARD CAPITAL MANAGEMENT#8 · 12,044 sh$219.1K-97.4%
Cormorant Asset Management#9 · 5,498 sh$100.0KNew
UBS Group AG#10 · 4,730 sh$86.0K+750.7%
MORGAN STANLEY#11 · 4,084 sh$74.3K+389.7%
VANGUARD FIDUCIARY#12 · 3,614 sh$65.7K-98.4%
BlackRock#13 · 1,702 sh$31.0K-99.6%
Tower Research Capital (TRC)#14 · 567 sh$10.3K-93.5%
Gen-Wealth Partners#15 · 165 sh$3.0K-99.5%
Operose Advisors#16 · 159 sh$2.9KNew
Fortitude Family Office#17 · 40 sh$728.00-99.5%
BARCLAYS PLC#18 · 27 sh$491.00+575.0%
Integrated Wealth Concepts#19 · 12 sh$218.00New
WELLS FARGO & COMPANY#20 · 10 sh$182.00New
Allworth Financial#21 · 8 sh$137.00New
Parallel Advisors#22 · 3 sh$55.00-99.6%
Westside Investment Management#23 · 1 sh$18.00-98.7%
Steward Partners Investment Advisory#24 · 1 sh$18.00New
JDM Financial Group#25 · 1 sh$18.00-99.7%
JPMORGAN CHASE#26 · 2 sh$2.00-99.6%
ROYAL BANK OF CANADA#27 · 1 sh$0.00-100.0%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.